MedTrace Logo

Blod Biomarkers for Stroke

NCT03941249 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-03-29

No results posted yet for this study

Summary

The purpose of the project is to investigate specific markers in blood samples from patients with stroke (ischemic or hemorrhagic). This could hopefully help in the early diagnostic to separate patients with ischemic stroke from those with hemorrhagic stroke as treatment are different and patients need to come quickly to the correct treatment site.

Conditions

Sponsors & Collaborators

  • Helle Klingenberg Iversen, MD, DmSc

    lead OTHER

Principal Investigators

  • Helle K Iversen, MD, DMSc · Department of clinical stroke research, Neurological department, Rigshospitalet, Glostrup

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2023-04-30
Completion
2023-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941249 on ClinicalTrials.gov